Cyclotide mela-2

General Information


DRACP ID  DRACP00570

Peptide Name   Cyclotide mela-2

Sequence  GKPTCGETCFKGKCYTPGCTCSYPLCKKD

Sequence Length  29

UniProt ID  Not available

PubChem CID  Not available

Origin  Melicytus latifolius

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma CC50=19.26±1.37µM Resazurin assay 24h 1
MM96L Melanoma Carcinoma CC50=1.30±0.44µM Resazurin assay 24h 1

Hemolytic Activity  Human erythrocytes: 50% Hemolysis>64µM

Normal (non-cancerous) Cytotoxicity  HFF-1: CC50=5.86±0.38µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00570

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys5<--->Cys19; Cys9<--->Cys21; Cys14<--->Cys26; NCB: Gly1<--->Asp29

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C132H208N34O41S6

Absent amino acids  AHIMNQRVW

Common amino acids  C

Mass  361928

Pl  8.37

Basic residues  5

Acidic residues  2

Hydrophobic residues  2

Net charge  3

Boman Index  -3790

Hydrophobicity  -60.34

Aliphatic Index  13.45

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  3355

Absorbance 280nm  119.82

Polar residues  17

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 26322745

Title  Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae

Doi 10.1021/acschembio.5b00454

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.